Background: Epidermal growth factor receptor (EGFR) inhibitor gefitinib (Iressa) is a synthetic anilinoquinazoline, which is extensively used for treating non small cell lung cancer. Apart from its anti-cancer…
with a poor prognosis. Little research has been conducted to directly compare erlotinib with gefitinib regarding the frequency of central nerve system recurrence. This is the first study to directly ... compare…
Gefitinib has demonstrated clinical efficacy in NSCLC patients harboring EGFR mutations or refractory to chemotherapy. However, most of NSCLC patients are with wild type EGFR, and had limited response ... gefitinib…
immunofluorescence and flow cytometry. We showed that cholesterol level in lipid rafts in gefitinib resistant NSCLC cell lines was remarkably higher than gefitinib sensitive cell line, and depletion of cholesterol…
Objective: Explore the effects and mechanism of AETC combined with Gefitinib in inhibiting non-small cell lung cancer PC9/R cell lines in vitro and in vivo. Methods: Culture human ... combination with certain…
precise stabilityindicating HPLC method has been developed and subsequently validated for the determination of Gefitinib in bulk and its pharmaceutical formulations. Separation was achieved on a Hypersil BDSC18column…
validated stability indicating RP-HPLC was developed for the estimation of Gefitinib related compounds as well as degradants on Inertsil C8 (250 × 4.6 mm, 5 μ) column using ... accuracy, precision and linearity as per…
expression have been demonstrated to mediate non-small cell lung cancer (NSCLC) resistance to Gefitinib. Here, we further investigated the effect of CyH on EGFR activation and PD-L1 expression ... Gefitinib sensitivity…
Epidermal growth factor receptor (EGFR) inhibitor gefitinib (Iressa) is a synthetic anilinoquinazoline, which is extensively used for treating non small cell lung cancer. Apart from its anti-cancer activities against…
Objective: Our objective is to explore the effects of pemetrexed combined with gefitinib on the life quality of patients with EGFR-TKI resisted advanced Non-Small Cell Lung Cancer (NSCLC ... random number table. The…
study is to observe the effect of gefitinib on the quality of life, the level of inflammatory factors, T cell subsets and serum tumor markers in elderly patients with ... patients were treated with routine supportive…
study was to explore the clinical efficacy and safety of two different dosage regimens, gefitinib plus carboplatin versus gemcitabine plus carboplatin in the treatment of advanced non-small-cell lung ... NSCLC). The…
precise, specific and cost effective spectrophotometric methods have been developed for the estimation of Gefitinib in bulk and its tablet formulation. Gefitinib was estimated at 250 nm in UV-spectroscopy ... acceptable…
sensitive RP-HPLC method with UV detection at 205 nm for routine analysis of Gefitinib in bulk and pharmaceutical formulations was developed. Chromatography was performed with mobile phase containing ... with flow rate…
Background: Epidermal growth factor receptor (EGFR) inhibitor gefitinib (Iressa) is a synthetic anilinoquinazoline, which is extensively used for treating non-small cell lung cancer. Apart from its anti-cancer…
orthotopic models. Remarkably, we found that the combination treatment of BO-1978 with gefitinib has enhanced efficacy against EGFR-mutated NSCLC and was superior to that of gefitinib or cisplatin
reported a rare case lung adenocarcinoma patient with primary T790M mutation treated with gefitinib as a fist line and osimertinib as a second line therapy
proliferation of different cancer cells including those from cervix, breast, leukemia and liver. Gefitinib is widely used to treat lung cancer, however, no response or resistance to gefitinib occurs ... many cases…
have been prepared by cost effective reagents and using these formamidines, prepared anticancer agents Gefitinib and Erlotinib, approved by US FDA for the treatment of non-small-cell-lung cancer
simple, sensitive and cost effective visible spectrophotometric methods were developed for the estimation of gefitinib in both bulk drug samples and tablets. These two methods are based on the formation